Antony Mattessich
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Antony Mattessich
Antony Mattessich was last confirmed as Board Member at Aura Biosciences, Inc. (AURA) in a filing dated April 25, 2024. Earlier roles on record: CEO and Board Member at Ocular Therapeutix, Inc (OCUL) until April 14, 2024. Ocular Therapeutix, Inc reported in an 8-K filed April 18, 2024 that Antony Mattessich resigned as director, effective April 14, 2024. Antony Mattessich has spoken on 15 earnings calls across 1 company, most recently for Ocular Therapeutix, Inc on November 7, 2023.
“On the Transition Date, Dr. Dugel succeeded Antony C. Mattessich as the Company's President and Chief Executive Officer, and Mr. Mattessich resigned from the board of directors of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-01-01–2024-04-25
Last confirmed by a filing; no departure on record
-
Start not stated–2024-04-14
-
Start not stated–2024-04-14
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.